eNews
Home page > Comments


Comments

Depomed sues FDA to get sales exclusivity for shingles pain drug

26.09.2012. | (Reuters) - Depomed Inc filed a lawsuit against U.S. health regulators, seeking market exclusivity for its shingles pain drug, which was designated as an orphan drug....


Оставите Ваш коментр
*Име:

Е-пошта:


*Ваш коментар:
:) :D ;) B-) :P :-o :( x-(

*Сигурносни број: